id	sid	eid	entity	type
bjos-8670171	1	1	1	CARDINAL
bjos-8670171	1	2	22	CARDINAL
bjos-8670171	1	3	2023	CARDINAL
bjos-8670171	1	4	braz j	WORK_OF_ART
bjos-8670171	1	5	sci	ORG
bjos-8670171	2	1	2023;22	CARDINAL
bjos-8670171	2	2	1	CARDINAL
bjos-8670171	2	3	university of technology	ORG
bjos-8670171	2	4	rustaq	ORG
bjos-8670171	2	5	oman	GPE
bjos-8670171	3	1	2	CARDINAL
bjos-8670171	3	2	the asoulaldeen university college	ORG
bjos-8670171	3	3	baghdad	GPE
bjos-8670171	3	4	iraq	GPE
bjos-8670171	4	1	3	CARDINAL
bjos-8670171	4	2	university of babylon	ORG
bjos-8670171	4	3	babel	GPE
bjos-8670171	4	4	iraq	GPE
bjos-8670171	5	1	4	CARDINAL
bjos-8670171	5	2	international medical university	ORG
bjos-8670171	5	3	kuala lumpur	GPE
bjos-8670171	5	4	malaysia	GPE
bjos-8670171	6	1	5	CARDINAL
bjos-8670171	6	2	apellis	NORP
bjos-8670171	6	3	waltham	GPE
bjos-8670171	6	4	ma, usa	ORG
bjos-8670171	6	5	6	CARDINAL
bjos-8670171	6	6	universiti malaya	GPE
bjos-8670171	6	7	kuala lumpur	GPE
bjos-8670171	6	8	malaysia	GPE
bjos-8670171	7	1	mazen m	PERSON
bjos-8670171	7	2	jamil university of technology	ORG
bjos-8670171	7	3	rustaq college	ORG
bjos-8670171	8	1	329	CARDINAL
bjos-8670171	8	2	oman	GPE
bjos-8670171	9	1	altair a. del bel	PERSON
bjos-8670171	9	2	june 19	DATE
bjos-8670171	9	3	2022	CARDINAL
bjos-8670171	9	4	september 23	DATE
bjos-8670171	9	5	2022	CARDINAL
bjos-8670171	9	6	iraqi	NORP
bjos-8670171	9	7	jamil al-obaidi1,2	PERSON
bjos-8670171	9	8	ahmed hadi2	PERSON
bjos-8670171	10	1	zeyad nazar al-talib3	PERSON
bjos-8670171	10	2	aqil m	PERSON
bjos-8670171	10	3	daher4	PERSON
bjos-8670171	10	4	mohammed al-adhamy5	PERSON
bjos-8670171	10	5	hany mohamed aly	PERSON
bjos-8670171	13	1	two	CARDINAL
bjos-8670171	13	2	iraqi	NORP
bjos-8670171	14	1	the university of baghdad	ORG
bjos-8670171	14	2	university of babylon	ORG
bjos-8670171	14	3	ub	ORG
bjos-8670171	14	4	one	CARDINAL
bjos-8670171	15	1	seven	CARDINAL
bjos-8670171	16	1	0.05	CARDINAL
bjos-8670171	17	1	three	CARDINAL
bjos-8670171	18	1	uob	ORG
bjos-8670171	18	2	32%	PERCENT
bjos-8670171	18	3	500mg	QUANTITY
bjos-8670171	19	1	62.1%	PERCENT
bjos-8670171	20	1	3	CARDINAL
bjos-8670171	21	1	ub	ORG
bjos-8670171	21	2	amoxicillin	PERSON
bjos-8670171	22	1	uob	ORG
bjos-8670171	23	1	iraq	GPE
bjos-8670171	27	1	iraq	GPE
bjos-8670171	28	1	https://orcid.org/0000-0001-5950-4498	PERSON
bjos-8670171	28	2	https://orcid.org/0000-0002-3504-4340 https://orcid.org/0000-0003-2021-747x https://orcid.org/0000-0003-0776-9288	PERSON
bjos-8670171	28	3	2	CARDINAL
bjos-8670171	28	4	al	GPE
bjos-8670171	29	1	braz j	PERSON
bjos-8670171	29	2	sci	ORG
bjos-8670171	30	1	2023;22	CARDINAL
bjos-8670171	31	1	400,000	CARDINAL
bjos-8670171	31	2	25000	CARDINAL
bjos-8670171	31	3	europe2	GPE
bjos-8670171	32	1	2050	DATE
bjos-8670171	32	2	10 million	CARDINAL
bjos-8670171	32	3	annually	DATE
bjos-8670171	32	4	infections2	PERSON
bjos-8670171	33	1	gram	CARDINAL
bjos-8670171	33	2	gram	CARDINAL
bjos-8670171	33	3	infections3	PERSON
bjos-8670171	34	1	infections4	PERSON
bjos-8670171	35	1	abscesses4	GPE
bjos-8670171	36	1	infections4	PERSON
bjos-8670171	37	1	three	CARDINAL
bjos-8670171	37	2	prescription5	PERSON
bjos-8670171	38	1	the american association of endodontics	ORG
bjos-8670171	38	2	aae	ORG
bjos-8670171	38	3	lymphadenopathy6	GPE
bjos-8670171	39	1	infections7	PERSON
bjos-8670171	40	1	about 10%	PERCENT
bjos-8670171	40	2	treatment8	DATE
bjos-8670171	43	1	iraqi	NORP
bjos-8670171	44	1	three	CARDINAL
bjos-8670171	44	2	iraqi	NORP
bjos-8670171	45	1	university of baghdad	ORG
bjos-8670171	46	1	3	CARDINAL
bjos-8670171	47	1	al	GPE
bjos-8670171	47	2	braz j	PERSON
bjos-8670171	47	3	sci	ORG
bjos-8670171	48	1	2023;22	CARDINAL
bjos-8670171	48	2	one	CARDINAL
bjos-8670171	49	1	7	CARDINAL
bjos-8670171	49	2	1	CARDINAL
bjos-8670171	50	1	three	CARDINAL
bjos-8670171	51	1	two	CARDINAL
bjos-8670171	52	1	one	CARDINAL
bjos-8670171	53	1	1	CARDINAL
bjos-8670171	53	2	1	CARDINAL
bjos-8670171	54	1	2	CARDINAL
bjos-8670171	54	2	2	CARDINAL
bjos-8670171	55	1	3	CARDINAL
bjos-8670171	55	2	3	CARDINAL
bjos-8670171	56	1	4	CARDINAL
bjos-8670171	56	2	4	CARDINAL
bjos-8670171	57	1	5	CARDINAL
bjos-8670171	57	2	5	CARDINAL
bjos-8670171	58	1	6	CARDINAL
bjos-8670171	58	2	6	CARDINAL
bjos-8670171	60	1	two	CARDINAL
bjos-8670171	60	2	university of baghdad	ORG
bjos-8670171	60	3	university of babylon	ORG
bjos-8670171	60	4	ub	ORG
bjos-8670171	60	5	one	CARDINAL
bjos-8670171	60	6	january 2019 to june 2019	DATE
bjos-8670171	61	1	446	CARDINAL
bjos-8670171	62	1	211	CARDINAL
bjos-8670171	62	2	95%	PERCENT
bjos-8670171	62	3	5%	PERCENT
bjos-8670171	63	1	two hundred and seventy-two	CARDINAL
bjos-8670171	63	2	99	CARDINAL
bjos-8670171	63	3	ub	ORG
bjos-8670171	63	4	70	CARDINAL
bjos-8670171	63	5	103	CARDINAL
bjos-8670171	64	1	61%	PERCENT
bjos-8670171	64	2	three	CARDINAL
bjos-8670171	65	1	year	DATE
bjos-8670171	65	2	three	CARDINAL
bjos-8670171	65	3	iraqi	NORP
bjos-8670171	65	4	one	CARDINAL
bjos-8670171	65	5	1)11,12	CARDINAL
bjos-8670171	68	1	4	CARDINAL
bjos-8670171	69	1	al	GPE
bjos-8670171	69	2	braz j	PERSON
bjos-8670171	69	3	sci	ORG
bjos-8670171	70	1	2023;22	CARDINAL
bjos-8670171	71	1	1	CARDINAL
bjos-8670171	71	2	first	ORDINAL
bjos-8670171	72	1	•	CARDINAL
bjos-8670171	72	2	625	CARDINAL
bjos-8670171	72	3	825 mg 1000 mg •	QUANTITY
bjos-8670171	72	4	150 mg 300 mg •	QUANTITY
bjos-8670171	72	5	flagyl®	ORG
bjos-8670171	72	6	250	CARDINAL
bjos-8670171	72	7	zithromax®	ORG
bjos-8670171	72	8	250	CARDINAL
bjos-8670171	72	9	250	CARDINAL
bjos-8670171	73	1	2	CARDINAL
bjos-8670171	73	2	•	CARDINAL
bjos-8670171	74	1	150 mg 300 mg	QUANTITY
bjos-8670171	74	2	3	CARDINAL
bjos-8670171	83	1	•	CARDINAL
bjos-8670171	84	1	1	CARDINAL
bjos-8670171	84	2	•	CARDINAL
bjos-8670171	85	1	2	CARDINAL
bjos-8670171	85	2	•	CARDINAL
bjos-8670171	86	1	3	CARDINAL
bjos-8670171	86	2	•	CARDINAL
bjos-8670171	87	1	4	CARDINAL
bjos-8670171	87	2	•	CARDINAL
bjos-8670171	88	1	5	CARDINAL
bjos-8670171	88	2	•	CARDINAL
bjos-8670171	89	1	6	CARDINAL
bjos-8670171	89	2	1	CARDINAL
bjos-8670171	89	3	spss	ORG
bjos-8670171	89	4	24	CARDINAL
bjos-8670171	92	1	0.05	CARDINAL
bjos-8670171	93	1	0.81	CARDINAL
bjos-8670171	94	1	5	CARDINAL
bjos-8670171	95	1	al	GPE
bjos-8670171	95	2	braz j	PERSON
bjos-8670171	95	3	sci	ORG
bjos-8670171	96	1	2023;22	CARDINAL
bjos-8670171	96	2	1	CARDINAL
bjos-8670171	96	3	three	CARDINAL
bjos-8670171	97	1	two hundred and seventy-two	CARDINAL
bjos-8670171	97	2	99	CARDINAL
bjos-8670171	97	3	186	CARDINAL
bjos-8670171	97	4	ub	ORG
bjos-8670171	97	5	70	CARDINAL
bjos-8670171	97	6	116	CARDINAL
bjos-8670171	98	1	103	CARDINAL
bjos-8670171	98	2	143	CARDINAL
bjos-8670171	99	1	61%	PERCENT
bjos-8670171	100	1	about two thirds	CARDINAL
bjos-8670171	100	2	one-third	CARDINAL
bjos-8670171	100	3	age of 22 years old	DATE
bjos-8670171	101	1	ouc	PERSON
bjos-8670171	101	2	37.9%	PERCENT
bjos-8670171	101	3	uob	ORG
bjos-8670171	101	4	36.4%	PERCENT
bjos-8670171	101	5	ub	ORG
bjos-8670171	101	6	25.7%	PERCENT
bjos-8670171	102	1	1	CARDINAL
bjos-8670171	102	2	3	CARDINAL
bjos-8670171	103	1	n percent	PERCENT
bjos-8670171	103	2	97	CARDINAL
bjos-8670171	103	3	175	CARDINAL
bjos-8670171	103	4	64.3	CARDINAL
bjos-8670171	103	5	99	CARDINAL
bjos-8670171	103	6	70	CARDINAL
bjos-8670171	103	7	103 37.9	CARDINAL
bjos-8670171	103	8	2	CARDINAL
bjos-8670171	104	1	500 mg	QUANTITY
bjos-8670171	104	2	32.7%	PERCENT
bjos-8670171	104	3	625 mg	QUANTITY
bjos-8670171	104	4	32.4%	PERCENT
bjos-8670171	104	5	first	ORDINAL
bjos-8670171	105	1	second	ORDINAL
bjos-8670171	105	2	18.8%	PERCENT
bjos-8670171	107	1	2	CARDINAL
bjos-8670171	108	1	2	CARDINAL
bjos-8670171	108	2	three	CARDINAL
bjos-8670171	108	3	ub	ORG
bjos-8670171	108	4	44.3%	PERCENT
bjos-8670171	108	5	first	ORDINAL
bjos-8670171	108	6	40.8%	PERCENT
bjos-8670171	108	7	uob	ORG
bjos-8670171	108	8	16.2 percent	PERCENT
bjos-8670171	109	1	6	CARDINAL
bjos-8670171	110	1	al	GPE
bjos-8670171	110	2	braz j	PERSON
bjos-8670171	110	3	sci	ORG
bjos-8670171	111	1	2023;22	CARDINAL
bjos-8670171	111	2	150 mg	QUANTITY
bjos-8670171	111	3	500	CARDINAL
bjos-8670171	111	4	250 mg azithromycin	QUANTITY
bjos-8670171	111	5	500 mg	QUANTITY
bjos-8670171	111	6	250 mg	QUANTITY
bjos-8670171	111	7	500 mg	QUANTITY
bjos-8670171	111	8	300	CARDINAL
bjos-8670171	111	9	1000 mg amoxicillin+clavulanic	QUANTITY
bjos-8670171	111	10	825	CARDINAL
bjos-8670171	111	11	625 mg amoxicillin	QUANTITY
bjos-8670171	111	12	500 mg amoxicillin 250	QUANTITY
bjos-8670171	111	13	0	CARDINAL
bjos-8670171	111	14	20 30 40 %	PERCENT
bjos-8670171	111	15	2	CARDINAL
bjos-8670171	112	1	2	CARDINAL
bjos-8670171	113	1	1	CARDINAL
bjos-8670171	113	2	1	CARDINAL
bjos-8670171	113	3	73	CARDINAL
bjos-8670171	113	4	75.3 24	TIME
bjos-8670171	113	5	110	CARDINAL
bjos-8670171	113	6	37.1	CARDINAL
bjos-8670171	113	7	83	CARDINAL
bjos-8670171	113	8	16	CARDINAL
bjos-8670171	113	9	16.2 0.001*ub	CARDINAL
bjos-8670171	113	10	55.7 31	TIME
bjos-8670171	113	11	44.3	CARDINAL
bjos-8670171	113	12	40.8	CARDINAL
bjos-8670171	113	13	1	CARDINAL
bjos-8670171	114	1	2	CARDINAL
bjos-8670171	117	1	3	CARDINAL
bjos-8670171	118	1	500 mg	QUANTITY
bjos-8670171	118	2	33.1%	PERCENT
bjos-8670171	118	3	300 mg	QUANTITY
bjos-8670171	118	4	22.8%	PERCENT
bjos-8670171	118	5	500 mg	QUANTITY
bjos-8670171	118	6	21.7%	PERCENT
bjos-8670171	118	7	second	ORDINAL
bjos-8670171	119	1	3	CARDINAL
bjos-8670171	119	2	uob	ORG
bjos-8670171	119	3	32.3%	PERCENT
bjos-8670171	119	4	2	CARDINAL
bjos-8670171	119	5	3	CARDINAL
bjos-8670171	119	6	7	CARDINAL
bjos-8670171	120	1	al	GPE
bjos-8670171	120	2	braz j	PERSON
bjos-8670171	120	3	sci	ORG
bjos-8670171	121	1	2023;22	CARDINAL
bjos-8670171	121	2	150 mg cephalexin	QUANTITY
bjos-8670171	121	3	500	CARDINAL
bjos-8670171	121	4	250 mg erythromycin	QUANTITY
bjos-8670171	121	5	500 mg azithromycin 1000 mg azithromycin	QUANTITY
bjos-8670171	121	6	500 mg	QUANTITY
bjos-8670171	121	7	250 mg	QUANTITY
bjos-8670171	121	8	500 mg	QUANTITY
bjos-8670171	121	9	250 mg	QUANTITY
bjos-8670171	121	10	300 mg	QUANTITY
bjos-8670171	121	11	150	CARDINAL
bjos-8670171	121	12	20 30 40 %	PERCENT
bjos-8670171	121	13	3	CARDINAL
bjos-8670171	122	1	3	CARDINAL
bjos-8670171	123	1	2	CARDINAL
bjos-8670171	123	2	1	CARDINAL
bjos-8670171	123	3	74	CARDINAL
bjos-8670171	123	4	76.3 23	TIME
bjos-8670171	123	5	23.7 0.072	QUANTITY
bjos-8670171	123	6	136	CARDINAL
bjos-8670171	123	7	22.3	CARDINAL
bjos-8670171	123	8	67	CARDINAL
bjos-8670171	123	9	32	CARDINAL
bjos-8670171	123	10	32.3 0.003*ub	PERCENT
bjos-8670171	123	11	22.3	CARDINAL
bjos-8670171	123	12	1	CARDINAL
bjos-8670171	124	1	2	CARDINAL
bjos-8670171	126	1	4	CARDINAL
bjos-8670171	127	1	7 days	DATE
bjos-8670171	127	2	first	ORDINAL
bjos-8670171	127	3	36.4%	PERCENT
bjos-8670171	127	4	25.4%	PERCENT
bjos-8670171	127	5	23.9%	PERCENT
bjos-8670171	127	6	5 and 3 days	DATE
bjos-8670171	129	1	three	CARDINAL
bjos-8670171	129	2	0.001	CARDINAL
bjos-8670171	129	3	ub	ORG
bjos-8670171	129	4	97.1%	PERCENT
bjos-8670171	129	5	ouc	PERSON
bjos-8670171	129	6	92.2%	PERCENT
bjos-8670171	129	7	7 days	DATE
bjos-8670171	129	8	uob	ORG
bjos-8670171	129	9	79.8%	PERCENT
bjos-8670171	129	10	4	CARDINAL
bjos-8670171	130	1	8	CARDINAL
bjos-8670171	131	1	al	GPE
bjos-8670171	131	2	braz j	PERSON
bjos-8670171	131	3	sci	ORG
bjos-8670171	132	1	2023;22	CARDINAL
bjos-8670171	132	2	15	CARDINAL
bjos-8670171	132	3	30 40 %	PERCENT
bjos-8670171	132	4	4	CARDINAL
bjos-8670171	133	1	4	CARDINAL
bjos-8670171	134	1	3	CARDINAL
bjos-8670171	134	2	1	CARDINAL
bjos-8670171	134	3	13	CARDINAL
bjos-8670171	134	4	13.4 84	TIME
bjos-8670171	134	5	17	CARDINAL
bjos-8670171	134	6	90.3	CARDINAL
bjos-8670171	134	7	20	CARDINAL
bjos-8670171	134	8	79.8 0.001*ub 2 2.9	CARDINAL
bjos-8670171	134	9	68	CARDINAL
bjos-8670171	134	10	97.1	CARDINAL
bjos-8670171	134	11	92.2	CARDINAL
bjos-8670171	134	12	1	CARDINAL
bjos-8670171	135	1	2:3 to 7 days	DATE
bjos-8670171	138	1	5	CARDINAL
bjos-8670171	138	2	six	CARDINAL
bjos-8670171	139	1	first	ORDINAL
bjos-8670171	139	2	28.3%	PERCENT
bjos-8670171	140	1	62.1%	PERCENT
bjos-8670171	140	2	6	CARDINAL
bjos-8670171	141	1	5	CARDINAL
bjos-8670171	141	2	six	CARDINAL
bjos-8670171	142	1	n %	PERCENT
bjos-8670171	142	2	195 71.7	QUANTITY
bjos-8670171	142	3	77 28.3	CARDINAL
bjos-8670171	143	1	9	CARDINAL
bjos-8670171	143	2	al-obaidi	ORG
bjos-8670171	144	1	al	GPE
bjos-8670171	144	2	braz j	PERSON
bjos-8670171	144	3	sci	ORG
bjos-8670171	145	1	2023;22	CARDINAL
bjos-8670171	145	2	129	CARDINAL
bjos-8670171	145	3	143 52.6	CARDINAL
bjos-8670171	145	4	226 83.1	QUANTITY
bjos-8670171	145	5	46	CARDINAL
bjos-8670171	145	6	179 65.8	CARDINAL
bjos-8670171	145	7	93	CARDINAL
bjos-8670171	145	8	191	CARDINAL
bjos-8670171	145	9	81	CARDINAL
bjos-8670171	145	10	29.8 q4_6	PRODUCT
bjos-8670171	145	11	103 37.9	CARDINAL
bjos-8670171	145	12	169 62.1	CARDINAL
bjos-8670171	149	1	first	ORDINAL
bjos-8670171	149	2	iraqi	NORP
bjos-8670171	150	1	iraqi	NORP
bjos-8670171	151	1	272	CARDINAL
bjos-8670171	151	2	iraqi	NORP
bjos-8670171	151	3	97	CARDINAL
bjos-8670171	151	4	175	CARDINAL
bjos-8670171	151	5	3	CARDINAL
bjos-8670171	151	6	iraqi	NORP
bjos-8670171	151	7	baghdad	GPE
bjos-8670171	151	8	babylon	GPE
bjos-8670171	152	1	18.8%	PERCENT
bjos-8670171	152	2	32.7%	PERCENT
bjos-8670171	152	3	32.4%	PERCENT
bjos-8670171	152	4	amoxicillin+clavulanic	ORG
bjos-8670171	152	5	625 mg	QUANTITY
bjos-8670171	153	1	ub	ORG
bjos-8670171	153	2	ouc	PERSON
bjos-8670171	154	1	the endodontic department	ORG
bjos-8670171	154	2	ub	ORG
bjos-8670171	155	1	iraqi	NORP
bjos-8670171	156	1	10	CARDINAL
bjos-8670171	157	1	al	GPE
bjos-8670171	157	2	braz j	PERSON
bjos-8670171	157	3	sci	ORG
bjos-8670171	158	1	2023;22	CARDINAL
bjos-8670171	158	2	spanish	NORP
bjos-8670171	158	3	first	ORDINAL
bjos-8670171	158	4	44%	PERCENT
bjos-8670171	158	5	42%)19	LAW
bjos-8670171	159	1	europe	LOC
bjos-8670171	159	2	first	ORDINAL
bjos-8670171	159	3	infections7	PERSON
bjos-8670171	160	1	guzmán-álvarez	PERSON
bjos-8670171	160	2	78.9%	PERCENT
bjos-8670171	160	3	fourth-year	DATE
bjos-8670171	160	4	first	ORDINAL
bjos-8670171	160	5	one	CARDINAL
bjos-8670171	160	6	mexico	GPE
bjos-8670171	162	1	one	CARDINAL
bjos-8670171	162	2	second	ORDINAL
bjos-8670171	162	3	30.9%	PERCENT
bjos-8670171	163	1	first	ORDINAL
bjos-8670171	164	1	1000 mg	QUANTITY
bjos-8670171	164	2	500	CARDINAL
bjos-8670171	164	3	first	ORDINAL
bjos-8670171	164	4	choice24	ORG
bjos-8670171	164	5	uob16 %	PERCENT
bjos-8670171	164	6	23%	PERCENT
bjos-8670171	165	1	300 mg	QUANTITY
bjos-8670171	166	1	two	CARDINAL
bjos-8670171	166	2	infections7	PERSON
bjos-8670171	167	1	erythromycin25	GPE
bjos-8670171	168	1	5-30%)26	CARDINAL
bjos-8670171	169	1	treatment27	GPE
bjos-8670171	170	1	the final year	DATE
bjos-8670171	170	2	3-7 days	DATE
bjos-8670171	170	3	7 days	DATE
bjos-8670171	170	4	89.0%	PERCENT
bjos-8670171	170	5	0.05	CARDINAL
bjos-8670171	171	1	aae	ORG
bjos-8670171	171	2	500 mg	QUANTITY
bjos-8670171	171	3	3 times/ day	DATE
bjos-8670171	171	4	3 to 7 days	DATE
bjos-8670171	171	5	prescription6	PERSON
bjos-8670171	172	1	300 mg	QUANTITY
bjos-8670171	172	2	6 hours	TIME
bjos-8670171	173	1	one	CARDINAL
bjos-8670171	173	2	99%	PERCENT
bjos-8670171	173	3	italian	NORP
bjos-8670171	173	4	3–7 days	DATE
bjos-8670171	173	5	treatment2	GPE
bjos-8670171	175	1	one	CARDINAL
bjos-8670171	175	2	3 to 7 days	DATE
bjos-8670171	175	3	removed5	PERSON
bjos-8670171	178	1	6	CARDINAL
bjos-8670171	179	1	1 (	PERCENT
bjos-8670171	179	2	28.3%	PERCENT
bjos-8670171	179	3	2 (	PERCENT
bjos-8670171	179	4	52.6%	PERCENT
bjos-8670171	180	1	two	CARDINAL
bjos-8670171	181	1	al	GPE
bjos-8670171	181	2	braz j	PERSON
bjos-8670171	181	3	sci	ORG
bjos-8670171	182	1	2023;22	CARDINAL
bjos-8670171	183	1	lithuania29	ORG
bjos-8670171	183	2	belgium30	PERSON
bjos-8670171	183	3	iran	GPE
bjos-8670171	183	4	80.6%	PERCENT
bjos-8670171	183	5	india	GPE
bjos-8670171	183	6	71.6%)31,32	DATE
bjos-8670171	184	1	administration33	ORG
bjos-8670171	185	1	16.9%	PERCENT
bjos-8670171	185	2	3	CARDINAL
bjos-8670171	185	3	14%	PERCENT
bjos-8670171	185	4	one	CARDINAL
bjos-8670171	185	5	31%	PERCENT
bjos-8670171	185	6	spanish	NORP
bjos-8670171	187	1	34.2%	PERCENT
bjos-8670171	187	2	4	CARDINAL
bjos-8670171	189	1	about one third	CARDINAL
bjos-8670171	189	2	iraqi	NORP
bjos-8670171	190	1	5th	ORDINAL
bjos-8670171	190	2	antibiotics7	ORG
bjos-8670171	191	1	about one-third	CARDINAL
bjos-8670171	194	1	6th	ORDINAL
bjos-8670171	195	1	62.1%	PERCENT
bjos-8670171	196	1	drainage7	NORP
bjos-8670171	197	1	final-year	DATE
bjos-8670171	198	1	iraqi	NORP
bjos-8670171	199	1	students35	PERSON
bjos-8670171	200	1	the middle east	LOC
bjos-8670171	200	2	students36	ORG
bjos-8670171	202	1	12	CARDINAL
bjos-8670171	202	2	al-obaidi	ORG
bjos-8670171	203	1	al	GPE
bjos-8670171	203	2	braz j	PERSON
bjos-8670171	203	3	sci	ORG
bjos-8670171	204	1	2023;22	CARDINAL
bjos-8670171	204	2	one	CARDINAL
bjos-8670171	205	1	iraqi	NORP
bjos-8670171	206	1	ub	ORG
bjos-8670171	208	1	first	ORDINAL
bjos-8670171	208	2	28.3%	PERCENT
bjos-8670171	209	1	iraqi	NORP
bjos-8670171	210	1	al-obaidi	ORG
bjos-8670171	210	2	ea	CARDINAL
bjos-8670171	210	3	zn al-talib	PERSON
bjos-8670171	210	4	al-adhami	PERSON
bjos-8670171	210	5	hma ahmed	PERSON
bjos-8670171	212	1	1	CARDINAL
bjos-8670171	214	1	2014	DATE
bjos-8670171	215	1	2022	CARDINAL
bjos-8670171	217	1	2	CARDINAL
bjos-8670171	217	2	salgarello s. antibiotic	PERSON
bjos-8670171	217	3	italy	GPE
bjos-8670171	220	1	10.1111/iej.13126	CARDINAL
bjos-8670171	221	1	3	CARDINAL
bjos-8670171	221	2	siqueira jf	PERSON
bjos-8670171	221	3	silva mg	PERSON
bjos-8670171	224	1	2008	DATE
bjos-8670171	224	2	nov;34(11):1332-6	EVENT
bjos-8670171	224	3	10.1016	CARDINAL
bjos-8670171	224	4	13	CARDINAL
bjos-8670171	224	5	al-obaidi	PERSON
bjos-8670171	224	6	al	GPE
bjos-8670171	225	1	braz j	PERSON
bjos-8670171	225	2	sci	ORG
bjos-8670171	226	1	2023;22	CARDINAL
bjos-8670171	226	2	4	CARDINAL
bjos-8670171	226	3	segura-egea jj	PERSON
bjos-8670171	226	4	gould k	PERSON
bjos-8670171	226	5	jonasson p	ORG
bjos-8670171	227	1	84	CARDINAL
bjos-8670171	228	1	10.1111	CARDINAL
bjos-8670171	228	2	epstein jb	PERSON
bjos-8670171	228	3	chong s	PERSON
bjos-8670171	229	1	assoc	ORG
bjos-8670171	230	1	2000	CARDINAL
bjos-8670171	230	2	nov;131(11):1600-9	DATE
bjos-8670171	230	3	10.14219	CARDINAL
bjos-8670171	231	1	6	CARDINAL
bjos-8670171	231	2	aae	ORG
bjos-8670171	231	3	aae	ORG
bjos-8670171	233	1	2017	CARDINAL
bjos-8670171	233	2	sep;43(9):1409-13	ORG
bjos-8670171	234	1	10.1016	CARDINAL
bjos-8670171	235	1	7	CARDINAL
bjos-8670171	235	2	segura-egea jj	PERSON
bjos-8670171	235	3	martín-gonzález j	PERSON
bjos-8670171	235	4	jiménez	PERSON
bjos-8670171	235	5	crespo-gallardo	PERSON
bjos-8670171	235	6	velasco-ortega e.	PERSON
bjos-8670171	236	1	j. 2017 aug;67(4):197-205	PERSON
bjos-8670171	237	1	10.1111/idj.12287	MONEY
bjos-8670171	238	1	8	CARDINAL
bjos-8670171	238	2	ajantha gs	PERSON
bjos-8670171	238	3	hegde v. antibacterial drug	PERSON
bjos-8670171	239	1	j. 2012 jun-jul;78(4):38	PERSON
bjos-8670171	240	1	9	CARDINAL
bjos-8670171	241	1	smith-jack f	ORG
bjos-8670171	242	1	scottish	NORP
bjos-8670171	243	1	2014	DATE
bjos-8670171	244	1	10.1111	CARDINAL
bjos-8670171	244	2	10	CARDINAL
bjos-8670171	245	1	velasco-ortega e	PERSON
bjos-8670171	245	2	torres-lagares	PERSON
bjos-8670171	245	3	velasco-ponferrada mc	PERSON
bjos-8670171	245	4	spanish	NORP
bjos-8670171	246	1	2010	DATE
bjos-8670171	247	1	10.1111	CARDINAL
bjos-8670171	248	1	11	CARDINAL
bjos-8670171	248	2	whitten bh	PERSON
bjos-8670171	248	3	gardiner dl	PERSON
bjos-8670171	248	4	jeansonne bg	PERSON
bjos-8670171	248	5	lemon	PERSON
bjos-8670171	250	1	assoc	ORG
bjos-8670171	251	1	1996	DATE
bjos-8670171	252	1	10.14219	CARDINAL
bjos-8670171	253	1	12	CARDINAL
bjos-8670171	253	2	hartwell gr	ORG
bjos-8670171	254	1	the american association	ORG
bjos-8670171	254	2	the year 2000	DATE
bjos-8670171	257	1	2002	DATE
bjos-8670171	258	1	10.1097/00004770-200205000-00012	CARDINAL
bjos-8670171	259	1	13	CARDINAL
bjos-8670171	259	2	perić m	PERSON
bjos-8670171	259	3	simeon p	PERSON
bjos-8670171	259	4	matijević j	PERSON
bjos-8670171	260	1	zagreb	GPE
bjos-8670171	260	2	croatia	GPE
bjos-8670171	262	1	2015	CARDINAL
bjos-8670171	262	2	13	CARDINAL
bjos-8670171	263	1	10.21101	CARDINAL
bjos-8670171	264	1	14	DATE
bjos-8670171	265	1	bansal r	PERSON
bjos-8670171	265	2	singh t, sood h	GPE
bjos-8670171	265	3	malviya hs	PERSON
bjos-8670171	267	1	2019	CARDINAL
bjos-8670171	267	2	24	CARDINAL
bjos-8670171	267	3	10.4103	CARDINAL
bjos-8670171	267	4	15	CARDINAL
bjos-8670171	268	1	licata f	PERSON
bjos-8670171	268	2	di gennaro g	PERSON
bjos-8670171	268	3	cautela	PERSON
bjos-8670171	268	4	nobile cga	PERSON
bjos-8670171	268	5	bianco a.	PERSON
bjos-8670171	268	6	italian	NORP
bjos-8670171	269	1	antimicrob	PERSON
bjos-8670171	270	1	2021	CARDINAL
bjos-8670171	271	1	10.1128	CARDINAL
bjos-8670171	272	1	16	CARDINAL
bjos-8670171	273	1	b. abraham s	PERSON
bjos-8670171	273	2	abdulla n	PERSON
bjos-8670171	273	3	awad m	PERSON
bjos-8670171	273	4	ahmed hma	PERSON
bjos-8670171	275	1	plos one.	ORG
bjos-8670171	276	1	10.1371	CARDINAL
bjos-8670171	276	2	17	CARDINAL
bjos-8670171	277	1	scaioli g	PERSON
bjos-8670171	277	2	gili	PERSON
bjos-8670171	277	3	masucci s	PERSON
bjos-8670171	277	4	bert f	PERSON
bjos-8670171	277	5	italy	GPE
bjos-8670171	278	1	plos one.	ORG
bjos-8670171	278	2	2015	CARDINAL
bjos-8670171	279	1	10.1371	CARDINAL
bjos-8670171	279	2	journal.pone.0122476	PRODUCT
bjos-8670171	279	3	18	CARDINAL
bjos-8670171	280	1	jain	ORG
bjos-8670171	280	2	singh	GPE
bjos-8670171	280	3	garg y	PERSON
bjos-8670171	280	4	saxena	PERSON
bjos-8670171	281	1	clin pharm	ORG
bjos-8670171	282	1	2015	CARDINAL
bjos-8670171	282	2	dec;7(1):12-6	ORG
bjos-8670171	282	3	10.4103/0976-0105.170584	CARDINAL
bjos-8670171	282	4	19	CARDINAL
bjos-8670171	283	1	velasco-ortega e	PERSON
bjos-8670171	283	2	spanish	NORP
bjos-8670171	285	1	2009	DATE
bjos-8670171	285	2	203	CARDINAL
bjos-8670171	286	1	10.1016/j.joen.2009.05.031	MONEY
bjos-8670171	287	1	20	CARDINAL
bjos-8670171	288	1	guzmán-álvarez	PERSON
bjos-8670171	288	2	medeiros m	PERSON
bjos-8670171	288	3	reyes lagunes li	ORG
bjos-8670171	288	4	campos	PERSON
bjos-8670171	288	5	ae	ORG
bjos-8670171	290	1	drug healthc	ORG
bjos-8670171	290	2	2012;4:55-9	CARDINAL
bjos-8670171	290	3	10.2147/dhps.s30984	CARDINAL
bjos-8670171	291	1	14	CARDINAL
bjos-8670171	292	1	al	GPE
bjos-8670171	292	2	braz j	PERSON
bjos-8670171	292	3	sci	ORG
bjos-8670171	293	1	2023;22	CARDINAL
bjos-8670171	293	2	21	CARDINAL
bjos-8670171	294	1	martín-jiménez m	PERSON
bjos-8670171	294	2	velasco-ortega e	PERSON
bjos-8670171	294	3	jiménez	PERSON
bjos-8670171	296	1	2018	DATE
bjos-8670171	297	1	10.1111	CARDINAL
bjos-8670171	297	2	22	CARDINAL
bjos-8670171	298	1	bolfoni	PERSON
bjos-8670171	298	2	pereira-cenci	PERSON
bjos-8670171	298	3	jacinto rc	GPE
bjos-8670171	298	4	brazilian	NORP
bjos-8670171	299	1	56	CARDINAL
bjos-8670171	299	2	10.1111	CARDINAL
bjos-8670171	299	3	23	CARDINAL
bjos-8670171	300	1	stein ge	PERSON
bjos-8670171	300	2	schooley s	PERSON
bjos-8670171	300	3	tyrrell kl	PERSON
bjos-8670171	300	4	goldstein ejc	PERSON
bjos-8670171	302	1	j antimicrob	PERSON
bjos-8670171	303	1	2007	DATE
bjos-8670171	304	1	10.1016	CARDINAL
bjos-8670171	305	1	baumgartner jc	PERSON
bjos-8670171	305	2	xia t. antibiotic	PERSON
bjos-8670171	307	1	2003	DATE
bjos-8670171	308	1	10.1097/00004770-200301000-00012	CARDINAL
bjos-8670171	309	1	25	CARDINAL
bjos-8670171	310	1	kuriyama t	PERSON
bjos-8670171	310	2	williams dw	PERSON
bjos-8670171	310	3	yanagisawa m	ORG
bjos-8670171	310	4	iwahara k	PERSON
bjos-8670171	310	5	nakagawa k	PERSON
bjos-8670171	310	6	800	CARDINAL
bjos-8670171	310	7	13	CARDINAL
bjos-8670171	312	1	2007	DATE
bjos-8670171	314	1	10.1111	CARDINAL
bjos-8670171	314	2	302x.2007.00365.x	CARDINAL
bjos-8670171	315	1	26	CARDINAL
bjos-8670171	316	1	australian	NORP
bjos-8670171	316	2	2017	DATE
bjos-8670171	317	1	australian	NORP
bjos-8670171	317	2	2017	CARDINAL
bjos-8670171	318	1	27	CARDINAL
bjos-8670171	318	2	gould k	PERSON
bjos-8670171	318	3	jonasson p	ORG
bjos-8670171	319	1	european	NORP
bjos-8670171	320	1	2018	DATE
bjos-8670171	320	2	jan;51(1):20-25	ORG
bjos-8670171	321	1	10.1111	CARDINAL
bjos-8670171	321	2	28	CARDINAL
bjos-8670171	322	1	van zuuren ej	PERSON
bjos-8670171	322	2	farman ag	ORG
bjos-8670171	322	3	al-langawi jh	PERSON
bjos-8670171	324	1	cochrane	PERSON
bjos-8670171	324	2	syst	ORG
bjos-8670171	324	3	2016	CARDINAL
bjos-8670171	325	1	10.1002/14651858.cd004969.pub4	CARDINAL
bjos-8670171	325	2	29	CARDINAL
bjos-8670171	326	1	skučaitė n	PERSON
bjos-8670171	326	2	lithuanian	NORP
bjos-8670171	328	1	2010;46(12):806	CARDINAL
bjos-8670171	329	1	10.3390	CARDINAL
bjos-8670171	330	1	30	DATE
bjos-8670171	331	1	mainjot	ORG
bjos-8670171	332	1	belgium	GPE
bjos-8670171	333	1	10.1111	CARDINAL
bjos-8670171	333	2	2591.2009.01642.x	CARDINAL
bjos-8670171	336	1	j calif	PERSON
bjos-8670171	336	2	assoc	GPE
bjos-8670171	337	1	1993	DATE
bjos-8670171	338	1	32	CARDINAL
bjos-8670171	339	1	nabavizadeh	PERSON
bjos-8670171	339	2	sahebi	PERSON
bjos-8670171	339	3	nadian	NORP
bjos-8670171	339	4	shiraz	GPE
bjos-8670171	340	1	iran	GPE
bjos-8670171	340	2	2011	DATE
bjos-8670171	340	3	10.22037	CARDINAL
bjos-8670171	340	4	33	CARDINAL
bjos-8670171	341	1	beck m	PERSON
bjos-8670171	341	2	weaver j.	PERSON
bjos-8670171	343	1	2000	DATE
bjos-8670171	344	1	10.1067	CARDINAL
bjos-8670171	344	2	34	CARDINAL
bjos-8670171	345	1	jacinto rc	GPE
bjos-8670171	345	2	correa signoretti fg	PERSON
bjos-8670171	345	3	scheffer de mattos v	PERSON
bjos-8670171	345	4	grecca fs, gomes bp	PERSON
bjos-8670171	346	1	betalactamic resistance profiles	ORG
bjos-8670171	348	1	2014 mar;40(3):339-44	DATE
bjos-8670171	349	1	10.1016	CARDINAL
bjos-8670171	350	1	35	CARDINAL
bjos-8670171	351	1	gyssens ic	PERSON
bjos-8670171	353	1	2013	DATE
bjos-8670171	353	2	202	CARDINAL
bjos-8670171	354	1	10.4161/viru.23706.	MONEY
bjos-8670171	355	1	lee cr	PERSON
bjos-8670171	355	2	lee jh	PERSON
bjos-8670171	355	3	kang lw	PERSON
bjos-8670171	355	4	jeong bc	PERSON
bjos-8670171	355	5	lee	PERSON
bjos-8670171	356	1	2015;2015:214021	CARDINAL
bjos-8670171	357	1	10.1155/2015/214021	CARDINAL
bjos-8670171	357	2	37	CARDINAL
bjos-8670171	357	3	stevens nt	PERSON
bjos-8670171	357	4	fitzpatrick f	PERSON
bjos-8670171	357	5	humphreys h.	PERSON
bjos-8670171	358	1	2019	DATE
bjos-8670171	359	1	10.1093	CARDINAL